|1.||Meanwell, Nicholas: 2 articles (03/2005 - 07/2004)|
|2.||Cianci, Christopher: 2 articles (03/2005 - 07/2004)|
|3.||Krystal, Mark: 2 articles (03/2005 - 07/2004)|
|4.||Zadjura, Lisa: 1 article (07/2004)|
|5.||Colonno, Richard: 1 article (07/2004)|
|6.||Clark, Junius: 1 article (07/2004)|
|7.||Yu, Kuo-Long: 1 article (07/2004)|
|8.||Yang, Zheng: 1 article (07/2004)|
|9.||Lamb, Lucinda: 1 article (07/2004)|
|10.||D'Arienzo, Celia: 1 article (07/2004)|
07/01/2004 - "In this report, the in vivo efficacy of BMS-433771 against RSV was further examined in the BALB/c mouse and cotton rat host models of infection. "
03/01/2005 - "The compound is active against both A and B groups of RSV, with an average EC(50) of 20 nM. BMS-433771 is also efficacious against RSV infection in two rodent models when dosed orally prior to infection. "
07/01/2004 - "Results of dose titration experiments suggested that RSV infection was more sensitive to inhibition by BMS-433771 treatment in the BALB/c mouse host than in the cotton rat. "
07/01/2004 - "BMS-433771 also exhibited in vivo efficacy following oral administration in a mouse model of RSV infection (C. "
07/01/2004 - "BMS-433771 efficacy against RSV infection was also demonstrated for mice that were chemically immunosuppressed by cyclophosphamide treatment, indicating that compound inhibition of the virus did not require an active host immune response."